Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation

NCT05443594 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT05443594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05443594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2023
Completion date
February 11, 2025
Enrollment
669 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation